Khelix Magnetic Sensor Electrophysiology Catheter (SS1-*-*-MAG)
CathRx, Ltd. · Decision date Oct 9, 2026
What did the FDA decide?
CathRx, Ltd. received a substantially equivalent (SESE) decision for the Khelix Magnetic Sensor Electrophysiology Catheter (SS1-*-*-MAG) under 510(k) number K262068. FDA recorded the decision on 2026-10-09, with the application received 06/22/2026. The device falls under product code DRF, regulation 870.1220, in the Cardiovascular specialty and review panel, and was handled as a Traditional 510(k) not reviewed by a third party. SESE means the device was cleared for marketing as substantially equivalent to a predicate; it is not a PMA approval.
The record identifies the applicant as CathRx, Ltd. of Rydalmere, Australia, with Acorn N Oakes, LLC listed as correspondent. The submission was not a combination product, and no predetermined change control plan was authorized. The public record does not state the predicate device, the specific magnetic sensor design or component changes, or any indications for use, so those details remain unknown from this source. No clinical or performance conclusions are drawn here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 9, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262068
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- CathRx, Ltd.
- Product code
- DRF
- Decision code
- SESE
- Decision date
- Oct 9, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Catheter, Electrode Recording, Or Probe, Electrode Recording.
- Applicant
- CathRx, Ltd.
- Product code
- DRF
- FDA device class
- 2
FDA decision timeline
K262068 received
Application receipt date recorded by FDA.
K262068 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
CathRx, Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Rydalmere
Sources and methodology
- Original FDA record: K262068
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records